Recipharm Appoints New Directors, Business Management to Further Strengthen European Sales Drive
Recipharm has appointed two new Directors of Business Management. These appointments form part of Recipharm’s strategic drive to increase the volume of its business and revenues in key European markets.
Henning Neubauer has joined the Business Management team at Recipharm, taking on the position of Business Director for Northern Germany and the Netherlands. In parallel, Antonio Lopez also joins the team in the role of Business Director for Spain and Southern France.
Previously, Neubauer was Chief Operating Officer (COO) at a German start-up company in Hamburg dealing with generic products, OTC and Rx. Prior to that, he worked for more than 10 years at Haupt Pharma as Head of Customer Service and Sales, responsible for leading the Customer Service Team and key account management. He has a degree and Diploma in Marketing from the Open University of Bad Harzburg.
Antonio Lopez, has previous experiences in Business Development and partnering, logistics, compliance and regulatory activities in the role as VP of Operations in Flavine, a US trading company involved in generics APIs and finished dosage forms. Prior to this, he worked for more than 20 years at the Spanish pharmaceutical company Grupo Uriach. Antonio graduated with a Pharmacist degree from the University of Barcelona and holds a Masters in Business Administration from Barcelona’s Esade Business School.
As a further initiative to bolster the Business Management organisation, Åsa Wilander joined the team in mid-January in the new role of Key Account Director for the Nordic region. In this role, Åsa will be responsible for co-ordinating customer management and commercial aspects, as well as developing relationships with a selected number of customers. Åsa has been with Recipharm since 2007. To date, she has been working as General Manager of the Höganäs facility and led a significant expansion of the company. She has some 30 years experience of the pharmaceutical industry including the leadership of a contract manufacturing supply team at Pfizer.
Commenting on the new appointments, Kenth Berg, VP Business Management Recipharm, stated: “I am very pleased to have such talent join our business management structure. Europe is one of our key markets and we look forward to utilising the respective skills and expertise of Henning and Antonio to further enhance our European sales drive in Germany, the Netherlands and Spain.”
He continued: “Indeed post our recent IPO, this is an exciting time to plan ahead and expand our revenues and turnover across our international operations of which Europe is a highly important component”.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance